solo1: maintenance olaparib in advanced brca ovarian cancer
Published 6 years ago • 1.9K plays • Length 10:34Download video MP4
Download video MP3
Similar videos
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
7:38
results from phiii solo1 trial in brcam ovarian cancer
-
3:56
solo1 trial of maintenance olaparib in advanced ovarian cancer | susana banerjee
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
7:28
comment on solo1 for advanced ovarian cancer
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib
-
1:25
dr. zakashansky on solo2 with maintenance olaparib in relapsed brca1/2 ovarian cancer
-
5:25
solo-1: frontline olaparib maintenance therapy in ovarian cancer
-
3:58
solo-1: practice changing data on olaparib for ovarian cancer
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
3:37
selecting patients to be treated with maintenance olaparib in the paola-1 trial
-
6:03
olaparib maintenance for recurrent ovarian cancer
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
3:42
comment on solo1 trial
-
1:50
results for maintenance olaparib in brca-mutated platinum-sensitive ovarian cancer
-
2:48
rationale for olaparib in advanced ovarian cancer
-
4:14
olaparib continues to show positive results in advanced ovarian cancer - 7 year data
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer